Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nitto Denko Corp.
DescriptionDaily insulin skin patch using PassPort system
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today